All In MedTech

Device Trial Radar · NCT06923774

European Real-World Registry for Use of the Ion Endoluminal System

A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System

Last checked: Nov 21, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,200

Planned (sponsor's estimate)

Start

Sep 9, 2025

Primary completion

Oct 2029

Study completion Oct 2029

Sponsor

Lead sponsor
Intuitive SurgicalPublic (ISRG)
Sponsor type
Industry
First posted
Apr 11, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to collect collect real-world data for the Ion endoluminal system.

Conditions

  • Pulmonary Nodule
  • Lung Cancer

Interventions

  • Ion endoluminal systemDevice

    Lung nodule biopsy and/or localization procedure using the Ion endoluminal system per sites' standard of care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic YieldTime frame: Intra-procedure through 24 month post-procedure

Locations

9 sites in 4 countries. Site status is shown where the registry gives one.

  • CHU de Brest, Hôpital de La Cavale Blanche

    Brest, France · Not yet recruiting

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.